GeneFerm Biotechnology Co., Ltd.
TWO: 1796.TWO0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Taipei Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Jinde Jin
- Employees
- 288
- Headquarters
- Tainan City, Taiwan
- IPO year
- 2016
- Market cap
- NT$1.6B
- Website
- https://www.geneferm.com
Loading 1796…
Loading profile data…Frequently asked questions about 1796
What does GeneFerm Biotechnology Co., Ltd. (1796.TWO) do?
GeneFerm Biotechnology Co., Ltd. develops, manufactures, and sells fermented health care products in Taiwan and internationally. The company offers microbial fermentation products, which includes mushrooms, lactic acid bacteria, bacteria, yeast, and algae; bio fermented ingredients, such as nattomena, natto fermented powder, red yeast rice ferme...
Where does 1796.TWO trade?
GeneFerm Biotechnology Co., Ltd. (1796.TWO) trades on the Taipei Exchange.
What sector is 1796.TWO in?
GeneFerm Biotechnology Co., Ltd. (1796.TWO) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of GeneFerm Biotechnology Co., Ltd.?
Jinde Jin is the chief executive officer of GeneFerm Biotechnology Co., Ltd. (1796.TWO).
Where is GeneFerm Biotechnology Co., Ltd. headquartered?
GeneFerm Biotechnology Co., Ltd. is headquartered in Taiwan.
Does 1796.TWO pay a dividend?
Yes — GeneFerm Biotechnology Co., Ltd. (1796.TWO) paid a trailing twelve-month dividend of TWD 2.00 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 1796.TWO go public?
GeneFerm Biotechnology Co., Ltd. (1796.TWO) completed its initial public offering in 2016.